Endurance28 — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Combinati Incorporatedcombinati.comMay 2018

Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events.

BiotechDeep TechHardwarePalo Alto, US

Michael Mokelke(Director)Ju-Sung (Paul) Hung(Executive Officer, Director)Charles Collins(Director)

Co-investorsBand of Angels BayMed Venture Partners IT-Farm Corporation

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.